Cognitive behavioral therapy

Studies of cognitive behavioral therapy in people

22 studies gave cognitive behavioral therapy to people and measured what changed

What changedDesignPeopleSource

no change: Has no effect on brain-predicted age differenceβ = 0.01 years, 95% CI [-0.82, 0.84]; p = .985

Randomized trial38 peoplerelatively youngPatient cohortsJournal of psychiatric research, Oct 16, 2026

up: Improves hot flush problem rating-1.47 points (95% CI -2.29 to -0.65, p < 0.001)

down: Decreases menopausal symptoms

Randomized trial12 weeks100 peopleWomenPostmenopausal womenMaturitas, Aug 21, 2026

up: Improves physical activity adherence511.00 to 897.17 MET-minutes/week vs 360.67 to 310.83 MET-minutes/week

down: Decreases systolic blood pressure-13.87 mmHg vs -5.60 mmHg

no change: Has no effect on diastolic blood pressure

Trialtwo weeks30 peopleOlder adults; in older adults with hypertensionJurnal Ners, Aug 21, 2026

down: Decreases vasomotor symptoms

up: Improves quality of life

down: Decreases anxiety

Randomized trial50 peopleWomenPostmenopausal women; postmenopausal womenClimacteric : the journal of the International Menopause Society, Jun 9, 2026

no change: Has no effect on Pittsburgh Sleep Quality Index

Randomized trialone month135 peopleWomen60.1 ± 5.9 yearsPostmenopausal women; Older adults; with placebo or controlCurrent aging science, Apr 9, 2026

down: Decreases depressive symptoms

Randomized trial12 months155 peoplemean age 81.8 ± 6.4 years (range 64–96 years)Patients admitted for an acute physical illness aged 65 years or older with Hospital Anxiety and Depression Scale score > 7BMC geriatrics, Feb 7, 2026

down: Decreases depression-42.1% (from M = 8.74 to M = 5.06, P = 0.001)

down: Decreases anxiety-56.2% (from M = 6.98 to M = 3.06, P = 0.004)

Treated cohorteight sessions16 peopleWomenPostmenopausal womenMenopause (New York, N.Y.), Jan 27, 2026

down: Decreases insomniaps < .001

down: Decreases anxietyps < .001

up: Improves sleep efficiencyps < .001

Randomized trial80 peopleolder adultsOlder adults; insomniamedRxiv, Dec 12, 2025

down: Decreases anxiety

down: Decreases somatic menopausal symptoms

down: Decreases Insomnia Severity Index

Randomized trial6 weeks53 peopleWomenperimenopausalJournal of mid-life health, Dec 8, 2025

down: Decreases menopausal symptoms

up: Improves psychological well-being

up: Improves quality of life

Trialshort-term24 peopleWomenPostmenopausal women; symptomatic perimenopausal and postmenopausal womenPost reproductive health, Nov 25, 2025

down: Decreases disability score2.1 [0.4] vs. 3.4 [0.5]

Randomized trial8 weeks54 peopleBothmean age, 83.9 yearsPatients 65 years or older who had undergone TAVR and planned for home dischargeJournal of the American Geriatrics Society, Apr 2, 2025

down: Decreases fatigue52.5 vs. 59.32

up: Improves self-efficacy7.23 vs. 5.89

up: Improves quality of life7.58 vs. 6.11

TrialWeek 1040 people85%, n = 34 were femalemean age of 70.28 years (SD = 6.76 years)Older adults aged ≥55 years with osteoarthritis or rheumatoid arthritisJournal of gerontological nursing, May 1, 2024

up: Improves general healthd = 0.63

up: Improves physical Summary Indexd = 0.56

Randomized trial8 weeks55 people63.6% were womenmean age of 53.0 years (SD = 5.8)Adults aged 45 years or older residing in Galicia with normal cognitive functioningDigital health, Feb 20, 2024

no change: Has no effect on functional impairment

Randomized trial6 weeks1,120 peopleaged 55 years and olderOlder adults; living aloneAnnals of internal medicine, Apr 24, 2023

down: Decreases worry

Randomized trialsix months after intervention completion500 peopleage 60+ yearsOlder adults; worried older adultsThe American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, Feb 6, 2022

down: Decreases fatigue-7.2, 97.5% CI -12.7 to -1.7; P = 0.003

up: Improves quality of life10.2, 95% CI 2.4 to 17.9; P = 0.011

Randomized trial12 weeks134 peopleBothmean 63 yearsOlder adults; advanced cancer patients with severe fatigue during treatmentAnnals of oncology : official journal of the European Society for Medical Oncology, Jan 1, 2020

down: Decreases social anxiety symptom severityCohen's d = 1.46

up: Increases glutathione peroxidase

no change: Has no effect on telomere length

Trial46 peopleBothPatient cohortsTranslational psychiatry, Dec 19, 2019

down: Decreases fear of falling

down: Decreases fear avoidance behavior

up: Improves balance

Randomized trial8 weeks89 peoplePatient cohortsStroke, Dec 7, 2018

down: Decreases fear of falling

Randomized trial8 weeks119 peopleelderlyOlder adultsRevista espanola de geriatria y gerontologia, Nov 24, 2018

down: Decreases depressionHADS 18.8 to 11.4 vs 18.1 to 21.6 in controls

up: Improves physical function

Randomized trial4 months155 people82 ± 6 yearsOlder adults; geriatric patients hospitalized for acute somatic illnessJournal of the American Medical Directors Association, Dec 9, 2016

down: Decreases fear of falling-4.02 FES-I points; 95% CI -5.95 to -2.1

down: Decreases anxiety and depression-1 HADS point; 95% CI -1.6 to -0.3

no change: Has no effect on falls

Randomized trial12 months415 peopleBoth≥ 60 yearsOlder adults; community-dwelling older adults with excessive fear of falling attending falls servicesHealth technology assessment (Winchester, England), Jul 1, 2016

down: Decreases insomnia

up: Improves health-related quality of life

no change: Has no effect on physical disability

Randomized trial4 months141 people60 years and olderOlder adults; Rural adults with generalized anxiety disorderThe American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, Apr 15, 2016